Picture of DSM-Firmenich AG logo

DSFIR — DSM-Firmenich AG News Story

0.000.00%
nl flag iconLast trade - 00:00
IndustrialsBalancedLarge Cap

dsm-firmenich shares rise after Q2 earnings beat

BUZZ-dsm-firmenich shares rise after Q2 earnings beat

** Shares in dsm-firmenich DSFIR.AS rise 9% after the European chemicals maker reported Q2 results above market estimates

** The company's adjusted EBITDA came in at €466 million ($533 million), beating consensus of €452 million

** Jefferies says in a note all divisions beat its estimates, noting the double-digit growth in fine fragrance

** The group keeps its full-year organic sales growth (OSG) guidance of 2-4%, saying growth should come at the top end of the guidance

** J.P.Morgan says the strong acceleration in growth in June on easing Middle East tensions "might give bulls some fodder to argue that 2H OSG guidance may be conservative"

** But strong OSG growth may reflect temporary customer stockpiling, while full-year margin guidance implies a sharper improvement than seen in recent years, JPM adds

** The shares were up 9.14% at 0705 GMT, among the top movers on the STOXX 600 .STOXX index and on top of Amsterdam blue chips .AEX index

($1 = 0.8738 euros)


(Reporting by Vera Dvorakova)

((vera.dvorakova@thomsonreuters.com))

Recent news on DSM-Firmenich AG

See all news